SCHEMBL3724007

SCHEMBL3724007

CC(=O)c1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)O)cc1

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.92
HTT P42858 1/20 0.92
TSHR P16473 1/20 0.67
L3MBTL1 Q9Y468 3/20 0.65
MAPK1 P28482 2/20 0.65
POLB P06746 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
APOBEC3A P31941 1/20 0.60
APOBEC3G Q9HC16 1/20 0.60
NPC1 O15118 1/20 0.57
MAPT P10636 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
KDM4E B2RXH2 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MMP2 P08253 1/20 0.52
MMP9 P14780 1/20 0.52
LMNA P02545 1/20 0.51
CA2 P00918 1/20 0.51
MMP8 P22894 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5560406 0.96 ALDH1A1 (1.00) ALDH1A1HTTTSHRL3MBTL1MAPK1
SCHEMBL2706429 0.85 ALDH1A1 (0.68) ALDH1A1HTTTSHRPOLBKDM4E
SCHEMBL696505 0.85 ALDH1A1 (0.68) ALDH1A1HTTTSHRL3MBTL1MAPK1
SCHEMBL2706426 0.85 ALDH1A1 (0.68) ALDH1A1HTTTSHRPOLBKDM4E
SCHEMBL696506 0.85 ALDH1A1 (0.68) ALDH1A1HTTTSHRL3MBTL1MAPK1
SCHEMBL2636629 0.85 ALDH1A1 (0.68) ALDH1A1HTTTSHRL3MBTL1MAPK1
SCHEMBL31087000 0.85 MAPK1 (0.71) ALDH1A1HTTTSHRL3MBTL1MAPK1
Water SCHEMBL5497101 0.84 ALDH1A1 (0.67) ALDH1A1HTTTSHRL3MBTL1MAPK1
Hydrochloric Acid SCHEMBL4077465 0.84 ALDH1A1 (0.67) ALDH1A1HTTTSHRL3MBTL1MAPK1
Hydrochloric Acid SCHEMBL4077466 0.84 ALDH1A1 (0.67) ALDH1A1HTTTSHRL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US claimed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO claimed
US-20260144730-A1 COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-05-28 US disclosed
US-20260083715-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-03-26 US disclosed
EP-4692062-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME Amorepacific Corporation (KR) 2026-02-11 EP disclosed
WO-2024205303-A1 NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME (주)아모레퍼시픽 2024-10-03 WO disclosed
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US disclosed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144730-A1 COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND TYR, ATG13, ARGLU1 ALDH1A1 1443/4885HTT 1805/4885TSHR 3528/4885
US-20260083715-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND ARG1, MSR1, TLR1 ALDH1A1 3501/4885HTT 4042/4885TSHR 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.